0 0 0 -0.00920245398773003 -0.00920245398773003 -0.00757849151930714 -0.00757849151930714 -0.00396968603392275
Sign Up Today X
Thanks for submitting the form.
Stockreport

Does BioMarin Pharmaceutical (BMRN) Price Weakness Contrast With Its Cash Flow Valuation? [Yahoo! Finance]

BioMarin Pharmaceutical Inc. (BMRN)  More Company Research Source: Yahoo! Finance
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
The stock trades at US$57.71, with a 7 day return of 3.9% decline, a 30 day gain of 8.3%, and a 1 year return of 9.6% decline, which suggests that the market's view of its prospects and risk has been shifting recently. Recent attention on BioMarin has focused on its position in rare disease treatments and how its approved therapies and late stage pipeline could affect long term revenue visibility. At the same time, investors have been weighing regulatory milestones and product uptake, which helps explain some of the recent share price moves. Our valuation work gives BioMarin a 3 out of 6 valuation score . Next we will compare what different valuation approaches say about that score and point you to an alternative way to think about value by the end of the article. Find out why BioMarin Pharmaceutical's -9.6% return over the last year is lagging behind its peers. A Discounted Cash Flow, or DCF, model estimates what a company might be worth by projecting its future cash flows a [Read more]
IMPACT SNAPSHOT EVENT TIME: BMRN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
BMRN alerts
from News Quantified
BMRN
NEWS
BMRN
Earnings
BMRN
Analyst Actions
BMRN
SEC Filings
Stockreport

Does BioMarin Pharmaceutical (BMRN) Price Weakness Contrast With Its Cash Flow Valuation? [Yahoo! Finance]

BioMarin Pharmaceutical Inc.  (BMRN) 
More Company Research Source: Yahoo! Finance
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
The stock trades at US$57.71, with a 7 day return of 3.9% decline, a 30 day gain of 8.3%, and a 1 year return of 9.6% decline, which suggests that the market's view of its prospects and risk has been shifting recently. Recent attention on BioMarin has focused on its position in rare disease treatments and how its approved therapies and late stage pipeline could affect long term revenue visibility. At the same time, investors have been weighing regulatory milestones and product uptake, which helps explain some of the recent share price moves. Our valuation work gives BioMarin a 3 out of 6 valuation score . Next we will compare what different valuation approaches say about that score and point you to an alternative way to think about value by the end of the article. Find out why BioMarin Pharmaceutical's -9.6% return over the last year is lagging behind its peers. A Discounted Cash Flow, or DCF, model estimates what a company might be worth by projecting its future cash flows a [Read more]
IMPACT SNAPSHOT
EVENT TIME:
BMRN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS